Introduction
============

Postoperative cognitive dysfunction (POCD) is a common complication following surgery.[@b1-tcrm-12-081],[@b2-tcrm-12-081] The incidence of POCD in the population undergoing noncardiac surgery has been reported to be as high as 9.1%--17% at day 7 following surgery.[@b3-tcrm-12-081],[@b4-tcrm-12-081] Increasing age has been reported to be associated with higher risk of POCD, and documented POCD lasting 3 months has been reported to be 12.7% in elderly patients who usually have preexisting impairment of cerebral oxygenation before surgery.[@b5-tcrm-12-081] These studies suggest that preexisting impairment of cerebral oxygenation may be a factor in deteriorating POCD; however, the mechanism is unclear.

A recent study in animals indicated that long-term administration of isoflurane, exceeding 4 hours, may induce cognitive impairment by reducing the *N*-methyl-D-aspartate receptor subunit NR2B and the phosphorylation of extracellular signal-regulated kinase 1/2.[@b6-tcrm-12-081] A previous clinical study also indicated that optimizing anesthetics and monitoring cerebral oxygenation could reduce POCD in older patients.[@b7-tcrm-12-081] These studies suggest that anesthetics may play a vital role in POCD by changing the cerebral oxygenation. Propofol and sevoflurane are commonly used anesthetics for sedation in general anesthesia, and their effects on POCD have raised the concerns of researchers. It was reported that, when compared to sevoflurane, higher dosage of propofol can further decrease cerebral blood flow (CBF),[@b8-tcrm-12-081] which has been, in combination with cerebral oxygenation saturation, used to assess POCD in patients undergoing valvular heart surgery.[@b9-tcrm-12-081] However, whether propofol and sevoflurane affect intraoperative cerebral oxygenation and further affect postoperative outcomes in nonheart surgery patients is unknown. In this study, sevoflurane or propofol was applied to different patients with preexisting cerebral oxygenation impairment in order to investigate the effects of propofol and sevoflurane on the cerebral oxygenation during general anesthesia and the postoperative cognitive outcomes.

Methods
=======

The experimental protocol was approved by the local research ethics committee (number 324, Sun Yat-sen University, 2012), and written informed consent was obtained from the patients. The inclusion criteria were physical status of I--III according to American Society of Anesthesiologists, age range of 40--75 years, presenting for elective abdominal surgery, and predicted surgery time ≥2 hours. Exclusion criteria were a history of cerebral vascular disease, preoperative cognitive dysfunction (illiterate group ≤17, primary and secondary school group ≤20, and junior high school and above group ≤24) assessed according to mini-mental state examination (MMSE), which is the most commonly used tool to screen cognitive function, language barriers, severe hearing, and visual impairment affecting cognitive function scores.

All patients (n=63) were administrated with jugular bulb catheterization and blood gas analysis was performed, including jugular venous bulb oxygen saturation (SjvO~2~) and cerebral blood flow/cerebral metabolic rate of oxygen (CBF/CMRO~2~). The SjvO~2~ was measured with blood gas analysis of blood samples from jugular venous bulb, CBF/CMRO~2~ was calculated by the equation: $${CBF}/{CMRO}_{2} = 100/(1.34 \times {Hb} \times \lbrack{SaO}_{2} - {SjvO}_{2}\rbrack + 0.003 \times \lbrack{PaO}_{2} - {PjvO}_{2}\rbrack)$$

Where Hb is hemoglobin, SaO~2~ is arterial oxygen saturation, PaO~2~ is arterial partial pressure oxygen, and PjvO~2~ is jugular venous partial pressure of oxygen.

Patients with decreased cerebral oxygenation (desaturation) defined as SjvO~2~ \<50% were randomly allocated into propofol group (group P, n=32) or sevoflurane group (group S, n=31). In group P, propofol target-controlled infusion was applied for induction and programmed with the pharmacokinetic parameters of Marsh to a preset plasma concentration of propofol at 4.0 μg/mL. In group S, patients were sedated via volatile induction and maintenance technique (sevoflurane 2%--4% at end-tidal concentration) by tidal volume. When patients lost consciousness, fentanyl (3 μg/kg) and rocuronium (0.6 mg/kg) were administered before tracheal intubation. Anesthesia was maintained with propofol (2--3 μg/mL in plasma) and remifentanil (0.1--0.3 μg/kg/min) for group P, and sevoflurane (1%--3% of end-tidal concentration) inhalation and remifentanil (0.1--0.3 μg/kg/min) for group S, respectively. Propofol and sevoflurane were adjusted to keep Narcotrend value between 40 and 60. Fentanyl (1 μg/kg) was administrated in both groups.

Patients were mechanically ventilated to maintain the end-tidal carbon dioxide (CO~2~) tension between 4.7 kPa and 5.5 kPa. Routine monitoring included invasive measurement of systemic blood pressure, heart rate, electrocardiogram, and pulse oxymetry. Blood samples in jugular venous bulb were taken at baseline, before anesthesia induction, after tracheal intubation, every hour during surgery, at the end of surgery, and at tracheal extubation for analysis of blood gas, oxygen saturation, and then calculation of CBF/CMRO~2~. The S100β protein was measured using enzyme-linked immunosorbent assay, according to the manufacturer's instructions. The Montreal Cognitive Assessment (MoCA) and MMSE were used to assess the cognition of patients, according to the guidelines. Estimated blood loss and amount of fluid or blood administered during the surgery were also recorded.

Trial registration
------------------

NCT01757561 (<https://www.clinicaltrials.gov/ct2/results?term=NCT01757561&Search=Search>).

Statistical analysis
--------------------

Statistical analysis was performed using SPSS for Windows 19.0 (IBM Corporation, Armonk, NY, USA). Continuous variables were presented as mean ± standard deviation \[SD\], and categorical variables were presented as frequency. Serial changes in cardiovascular SjvO~2~ were analyzed using repeated measures analysis of variance. *P*\<0.05 was considered to be statistically significant.

Results
=======

General information
-------------------

There was no significant difference between the two groups in general information, including age, gender, weight, and disease history ([Table 1](#t1-tcrm-12-081){ref-type="table"}, all *P*\>0.05). Furthermore, there was no significant difference in anesthesia time, surgical time, fluid infused during surgery, blood transfused, urine output, or blood loss between the two groups ([Table 2](#t2-tcrm-12-081){ref-type="table"}, *P*\>0.05). There was no significant difference in the administrated dosages of fentanyl, remifentanil, or morphine between the two groups (all *P*\>0.05) except the dosage of norepinephrine, which was not used in group P ([Table 2](#t2-tcrm-12-081){ref-type="table"}).

Cognitive function
------------------

As shown in [Table 3](#t3-tcrm-12-081){ref-type="table"}, the MMSE scores at baseline and at day 1 and day 7 following surgery were similar and there was no significant difference at different time points between the two groups (*P*\>0.05). Furthermore, the MMSE scores were not significantly different between group P and group S at all time points (all *P*\>0.05). The MoCA scores displayed similar changes with MMSE, and there was no significant difference between the two groups at different time points (*P*\>0.05; [Table 3](#t3-tcrm-12-081){ref-type="table"}).

SjvO~2~ and CBF/CMRO~2~
-----------------------

In both group S and group P, the SjvO~2~ increased during anesthesia induction at 1 hour, 2 hours, and the end of surgery. In group S, the SjvO~2~ also increased at extubation. But there was no significant difference between group P and group S during anesthesia induction and surgery ([Figure 1](#f1-tcrm-12-081){ref-type="fig"}).

The CBF/CMRO~2~ increased in group S during anesthesia induction at 1 hour, 2 hours, the end of surgery, and extubation, when compared to baseline. The CBF/CMRO~2~ increased in group P at the end of surgery and extubation but did not change at the end of surgery, when compared to baseline. The CBF/CMRO~2~ was significantly higher in group S than that in group P during anesthesia induction at 1 hour, 2 hours, and the end of surgery ([Figure 2](#f2-tcrm-12-081){ref-type="fig"}).

S100β protein
-------------

The level of S100β protein significantly increased at extubation and 1 day after surgery when compared to baseline in both groups (*P*\<0.05). However, there was no significant difference in the levels of S100β protein between group P and group S at baseline, after extubation, and day 1 following surgery (*P*\>0.05; [Table 4](#t4-tcrm-12-081){ref-type="table"}).

Discussion
==========

In this study, we compared the effects of propofol and sevoflurane on cerebral oxygenation and cognitive outcome in patients who underwent elective abdominal surgery. The results indicated that patients anesthetized with sevoflurane showed better cerebral oxygenation than those with propofol, and there was no significant difference in the SjvO~2~, incidence of POCD, and S100β protein levels between group S and group P.

POCD is a common postoperative complication that may reduce the life quality of patients and increase mortality.[@b10-tcrm-12-081] It was reported that cerebral oxygen desaturation during thoracic surgery could predict early POCD,[@b11-tcrm-12-081] was observed in many surgeries,[@b12-tcrm-12-081],[@b13-tcrm-12-081] and may be associated with POCD, delirium, and longer hospitalization.[@b14-tcrm-12-081],[@b15-tcrm-12-081] Furthermore, the cerebral oxygen desaturation or impairment may be related to the administration of anesthetics.[@b6-tcrm-12-081],[@b7-tcrm-12-081] General anesthetic propofol has been reported to reduce CBF in equivalent proportion to cerebral metabolism, while sevoflurane can reduce cerebral metabolism but not as much as propofol.[@b8-tcrm-12-081] SjvO~2~ is an indicator of global cerebral oxygen consumption and is independent of inhaled oxygen concentration during general anesthesia.[@b16-tcrm-12-081] It was reported that SjvO~2~ remained unchanged during mild-to-moderate hemodilution, but was significantly lower under propofol anesthesia when compared with those under sevoflurane/nitrous oxide anesthesia.[@b17-tcrm-12-081] These studies are consistent with the results of the present study showing that SjvO~2~ was increased at different time points. However, we did not find any significant difference between the two groups, suggesting that propofol and sevoflurane had similar effects on cerebral oxygen consumption.

Previous studies showed that, in total intravenous anesthesia with propofol--remifentanil, CBF decreased progressively with the decrease of cerebral electrical activity measured by bispectral index, while higher dose of sevoflurane increased the CBF despite a decrease in bispectral index value.[@b18-tcrm-12-081],[@b19-tcrm-12-081] These findings suggest the presence of an intrinsic dose-dependent vasodilatory effect of sevoflurane, which might have positive influence on patients with impaired baseline cerebral oxygenation. In the present study, the cerebral oxygenation was improved with significant increase in CBF/CMRO~2~ following sevoflurane inhalation. In contrast, CBF/CMRO~2~ only demonstrated a slight increase after intravenous anesthesia of propofol, suggesting that propofol has no significant influence on metabolic coupling, which was consistent with previous studies.[@b20-tcrm-12-081]--[@b22-tcrm-12-081] However, it has been reported that, during carotid endarterectomy, propofol could be advantageous in cognitive function over sevoflurane,[@b23-tcrm-12-081] which is inconsistent with the present study showing that cognition was not significantly affected in both groups. This inconsistency remains to be further studied.

S100β is a 21 kDa calcium-binding protein primarily localized in astrocytes and associated with POCD as a neurodegenerative biomarker.[@b24-tcrm-12-081],[@b25-tcrm-12-081] A study in mice showed that propofol and isoflurane increased the level of S100β and neuronal apoptosis but had no significant effect on cognition.[@b25-tcrm-12-081] However, the present study found that both groups showed normal S100β level and cognitive functions, suggesting that propofol and sevoflurane, at the dosage used in the present study, had no significant effect on cognition in the short term. Therefore, there is insufficient evidence to show that sevoflurane is better than propofol in those patients with impaired cerebral oxygenation. The comprehensive effects of general anesthetics such as propofol and sevoflurane on brain cells require further detailed studies.

Conclusion
==========

The present study demonstrated that sevoflurane improved the cerebral oxygenation of patients with impaired cerebral oxygenation when compared to propofol and that both sevoflurane and propofol have no significant effect on postoperative neurocognitive function in the short term.
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###### 

Characteristics of the patients

  Characteristics          Propofol group (n=32)   Sevoflurane group (n=31)   *P*-value
  ------------------------ ----------------------- -------------------------- -----------
  Sex (M/F)                23/9                    23/8                       0.836
  Age (years)              63.5±7.6                64.2±8.3                   0.728
  Weight (kg)              59.4±10.5               56.3±7.4                   0.182
  Height (cm)              165±6                   164±9                      0.605
  Hypertension             3                       5                          0.421
  Diabetes                 0                       1                          0.306
  Ischemic heart disease   1                       3                          0.286
  ASA class II/III         30/2                    25/6                       0.118

**Note:** Data presented as mean ± SD.

**Abbreviations:** M, male; F, female; ASA, American Society of Anesthesiologists.

###### 

Surgical data in the two groups

                          Propofol group (n=32)   Sevoflurane group (n=31)   *P*-value
  ----------------------- ----------------------- -------------------------- -----------
  Anesthesia time (min)   277.6±177.5             289.7±106.6                0.545
  Surgery time (min)      245.4±114.1             248.1±108.4                0.581
  Blood loss (mL)         282.4±234.5             255.0±313.4                0.98
  Fluid (mL)              2,873±1,001             3,250±1,177                0.33
  Norepinephrine (μg)     0                       272.5±366.7                0.0042
  Fentanyl (mg)           0.49±0.15               0.46±0.13                  0.6537
  Morphine (mg)           36±7.91                 37.81±6.51                 0.8656

**Note:** Data presented as mean ± SD.

###### 

MMSE and MoCA scores in the two groups

                      Test   Propofol group (n=32)   Sevoflurane group (n=31)   *P*-value
  ------------------- ------ ----------------------- -------------------------- -----------
  Baseline            MMSE   26.30±1.54              26.50±2.21                 0.3948
                      MoCA   22.44±3.12              22.43±3.80                 0.8814
  Day 1 postsurgery   MMSE   24.80±2.43              25.93±2.46                 0.1767
                      MoCA   19.40±4.98              20.93±4.32                 0.5086
  Day 7 postsurgery   MMSE   26.27±1.94              26.36±2.68                 0.3400
                      MoCA   21.40±4.24              21.21±5.39                 0.8107

**Note:** Data presented as mean ± SD.

**Abbreviations:** MMSE, mini-mental state examination; MoCA, Montreal Cognitive Assessment.

###### 

Changes in S100β protein levels in the two groups

                                                              Propofol group (n=32)                                       Sevoflurane group (n=31)
  ----------------------------------------------------------- ----------------------------------------------------------- -----------------------------------------------------------
  Presurgery                                                  505.57±169.95                                               502.38±149.35
  Postsurgery[\*\*](#tfn8-tcrm-12-081){ref-type="table-fn"}   630.56±126.47[\*](#tfn7-tcrm-12-081){ref-type="table-fn"}   648.29±142.34[\*](#tfn7-tcrm-12-081){ref-type="table-fn"}
  Day 1 postsurgery                                           536.46±200.84                                               616.59±146.98

**Notes:** Data presented as mean ± SD.

*P*\<0.05 versus presurgery.

Immediately after trachea extubation.
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